HomeCMPX • NASDAQ
Compass Therapeutics Inc.
add
$2.02
1.00%
Pre-market:(0.99%)+0.020
$2.04
Closed: May 16, 5:25:41 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.97M | 40.69% |
Net income | -16.63M | -54.19% |
Net profit margin | — | — |
Earnings per share | -0.12 | -50.00% |
EBITDA | -17.83M | -41.30% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.64M | -27.92% |
Total assets | 131.45M | -18.43% |
Total liabilities | 21.17M | 418.67% |
Total equity | 110.28M | — |
Shares outstanding | 138.28M | — |
Price to book | 2.50 | — |
Return on assets | -33.04% | — |
Return on capital | -36.14% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -16.63M | -54.19% |
Cash from operations | -13.21M | 4.90% |
Cash from investing | 11.59M | 382.70% |
Cash from financing | -815.00K | -104.68% |
Net change in cash | -2.44M | -339.53% |
Free cash flow | -7.59M | 26.88% |
Previous close
$2.00
Day range
$1.95 - $2.08
Year range
$0.77 - $4.08
Market cap
279.33M USD
Avg Volume
1.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
35
